SMARCA2 and neoplasm: Cell proliferation and DNA repair are critical determinants of tumor cell response to radiotherapy, and the involvement of SMARCA2 may influence this response (Lee et al., 2013; Su et al., 2019; Wang et al., 2019; Toulany et al., 2006; Hadjipanayis and DeLuca, 2005).